BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11805513)

  • 1. Synergism of RAD and cyclosporin A in prevention of acute rat corneal allograft rejection.
    Reis A; Megahed M; Reinhard T; Godehardt E; Braunstein C; Sundmacher R
    Cornea; 2002 Jan; 21(1):81-4. PubMed ID: 11805513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
    Hausen B; Boeke K; Berry GJ; Segarra IT; Christians U; Morris RE
    J Heart Lung Transplant; 1999 Feb; 18(2):150-9. PubMed ID: 10194039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAD, a new immunosuppressive macrolide in murine corneal transplantation.
    Reis A; Megahed M; Reinhard T; Braunstein C; Godehardt E; Sundmacher R
    Graefes Arch Clin Exp Ophthalmol; 2001 Sep; 239(9):689-92. PubMed ID: 11688669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
    Hausen B; Boeke K; Berry GJ; Christians U; Schüler W; Morris RE
    Ann Thorac Surg; 2000 Mar; 69(3):904-9. PubMed ID: 10750781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral efficacy of the macrolide immunosuppressant SDZ RAD and of cyclosporine microemulsion in cynomolgus monkey kidney allotransplantation.
    Schuurman HJ; Ringers J; Schuler W; Slingerland W; Jonker M
    Transplantation; 2000 Mar; 69(5):737-42. PubMed ID: 10755519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SDZ-RAD prevents manifestation of chronic rejection in rat renal allografts.
    Viklický O; Zou H; Müller V; Lacha J; Szabó A; Heemann U
    Transplantation; 2000 Feb; 69(4):497-502. PubMed ID: 10708101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation.
    Reis A; Megahed M; Reinhard T; Godehardt E; Spelsberg H; Braunstein C; Sundmacher R
    Transplantation; 2000 Nov; 70(9):1397-401. PubMed ID: 11087159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
    Hausen B; Gummert J; Berry GJ; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier MH; Morris RE
    Transplantation; 2000 Feb; 69(4):488-96. PubMed ID: 10708100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
    Hausen B; Ikonen T; Briffa N; Berry GJ; Christians U; Robbins RC; Hook L; Serkova N; Benet LZ; Schuler W; Morris RE
    Transplantation; 2000 Jan; 69(1):76-86. PubMed ID: 10653384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
    Hausen B; Boeke K; Berry GJ; Segarra I; Benet LZ; Christians U; Morris RE
    Transplantation; 1999 Apr; 67(7):956-62. PubMed ID: 10221478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection.
    Thompson P; Xu D; Brunette I; Chen H
    Transplant Proc; 1998 Jun; 30(4):1033-5. PubMed ID: 9636417
    [No Abstract]   [Full Text] [Related]  

  • 12. [Combined rapamycin eye drop in nanometer vector and poly (lactic acid) wafers of cyclosporine A effectively prevents high-risk corneal allograft rejection in rabbits].
    Jiang W; Sun HM; Li XR; Yuan XB; Wang YQ; Zhang SX; Tian EJ; Yuan JQ
    Zhonghua Yan Ke Za Zhi; 2009 Jun; 45(6):550-5. PubMed ID: 19957680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model.
    Nikolova Z; Hof A; Baumlin Y; Hof RP
    Transpl Immunol; 2001 Oct; 9(1):43-9. PubMed ID: 11680571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
    Longoria J; Roberts RF; Marboe CC; Stouch BC; Starnes VA; Barr ML
    J Thorac Cardiovasc Surg; 1999 Apr; 117(4):714-8. PubMed ID: 10096966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early clinical experience with a novel rapamycin derivative.
    Nashan B
    Ther Drug Monit; 2002 Feb; 24(1):53-8. PubMed ID: 11805723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluvastatin in combination with rad significantly reduces graft vascular disease in rat cardiac allografts.
    Gregory CR; Katznelson S; Griffey SM; Kyles AE; Berryman ER
    Transplantation; 2001 Sep; 72(6):989-93. PubMed ID: 11579289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model.
    Reis A; Reinhard T; Sundmacher R; Braunstein C; Godehardt E
    Br J Ophthalmol; 1998 Jun; 82(6):700-3. PubMed ID: 9797676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
    Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
    Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promotion of corneal allograft survival with leflunomide.
    Niederkorn JY; Lang LS; Ross J; Mellon J; Robertson SM
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3783-5. PubMed ID: 8088966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.